organization · Reporting owner
ALPHA CAPITAL ANSTALT
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Fabric.AI, Inc.
Report date May 04, 2018 · Filed May 08, 2018
Section 16 reporting ended · disclosed 2018-05-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 735,771 |
Reported balance
After 2018-05-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-04 · Sale · Disposed 10,000 · Balance 735,771 F1: This number includes some but not all the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. |
Filing footnotes · ownership attribution and instrument terms
F1: This number includes some but not all the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker.
Microbot Medical Inc.
Report date November 28, 2016 · Filed November 30, 2016
Section 16 reporting ended · disclosed 2016-11-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,776,457 |
Last balance in matching sequence
After 2016-11-28 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2016-11-28 · Other · Acquired 9,753,549 · Balance 9,753,549 F1: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. Row 2 · 2016-11-28 · Other · Disposed 7,977,092 · Balance 1,776,457 F1: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. |
| Convertible DebentureSEC Table II · derivative / convertible security · Conversion / exercise price $0.64 | Direct | 1,776,457 |
Reported balance
After 2016-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-28 · Other · Acquired 1,776,457 · Balance 1,776,457 F2: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer.
F2: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision.
F3: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2018 Filed May 8, 2018 18:08 UTC | Fabric.AI, Inc. WPCS · Entity 7732 | SaleCommon | 10,000 | $2.08 | $20,750.00 |
DisclosureSEC source: 0001213900-18-005669 · f4050418alpha_dropcar.xml · nonDerivative · entry 1 ALPHA CAPITAL ANSTALT · CIK 0001140358 · Sales reported on Form 144 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,771 F1 · balance_after: This number includes some but not all the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. Read SEC document |
| April 18, 2018 Filed Apr 20, 2018 16:09 UTC | Fabric.AI, Inc. WPCS · Entity 7732 | SaleCommon | 24,100 | $2.30 | $55,430.00 |
DisclosureSEC source: 0001213900-18-004755 · f4041818alphacap_dropcar.xml · nonDerivative · entry 1 ALPHA CAPITAL ANSTALT · CIK 0001140358 · Sales reported on Form 144 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780,200 F1 · balance_after: This number includes some but not all the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. Read SEC document |
| February 21, 2018 Filed Feb 21, 2018 22:13 UTC | Fabric.AI, Inc. WPCS · Entity 7732 | SaleCommon | 138,702 | $2.60 | $360,625.20 |
DisclosureSEC source: 0001213900-18-002166 · f4022118alphacapital_dropcar.xml · nonDerivative · entry 1 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780,407 F1 · balance_after: This number includes some but not all the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. Read SEC document |
| February 20, 2018 Filed Feb 20, 2018 22:15 UTC | Fabric.AI, Inc. WPCS · Entity 7732 | SaleCommon | 356,151 | $3.53 | $1,257,213.03 |
DisclosureSEC source: 0001213900-18-002125 · f4021618alphacapital_dropcar.xml · nonDerivative · entry 2 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 908,573 F1 · balance_after: This number does not include the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 22:15 UTC | Fabric.AI, Inc. WPCS · Entity 7732 | SaleCommon | 135,651 | $2.74 | $371,683.74 |
DisclosureSEC source: 0001213900-18-002125 · f4021618alphacapital_dropcar.xml · nonDerivative · entry 1 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,264,724 F1 · balance_after: This number does not include the securities described on Table II to the Form 3 filed on February 5, 2018, which are subject to a 9.99% blocker. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 22:34 UTC | Microbot Medical Inc. MBOT · Entity 6767 | OtherConvertible Debenture · Derivative | 1,776,457 | Not disclosed Strike: $0.64 | Not disclosed |
DisclosureSEC source: 0001213900-16-019069 · f4112816alpha_microbotmed.xml · derivative · entry 3 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776,457 Underlying: Common Stock · Not disclosed shares Expires not disclosed F2 · deemedExecutionDate: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F2 · shares: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · shares: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. F2 · price: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F2 · derivative.exercise_date: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F2 · derivative.expiration_date: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F2 · derivative.underlying_shares: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · derivative.underlying_shares: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. F2 · balance_after: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · balance_after: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 22:34 UTC | Microbot Medical Inc. MBOT · Entity 6767 | OtherCommon Stock | 7,977,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-16-019069 · f4112816alpha_microbotmed.xml · nonDerivative · entry 2 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776,457 F1 · deemedExecutionDate: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F1 · shares: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2 · shares: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · shares: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. F1 · price: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F1 · balance_after: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2 · balance_after: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · balance_after: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 22:34 UTC | Microbot Medical Inc. MBOT · Entity 6767 | OtherCommon Stock | 9,753,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-16-019069 · f4112816alpha_microbotmed.xml · nonDerivative · entry 1 ALPHA CAPITAL ANSTALT · CIK 0001140358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,753,549 F1 · deemedExecutionDate: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F1 · shares: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2 · shares: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · shares: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. F1 · price: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F1 · balance_after: Pursuant to a merger agreement effective as of November 28, 2016 reported in a Form 8-K filed by the Issuer on November 29, 2016, Alpha Capital Anstalt ("Alpha") was issued 9,753,549 shares of common stock, which immediately following the merger were surrendered by Alpha to the Issuer pursuant to the terms of a Right to Shares Agreement. The Right to Shares Agreement contains a 4.99% "blocker" provision designed to prevent Alpha from being a beneficial owner of more than 4.99% of the Issuer's Common Stock. Therefore, Alpha is no longer an affiliate of the Issuer. F2 · balance_after: In connection with the merger on November 28, 2016, Alpha exchanged a non-convertible note for a convertible debenture containing a 4.99% "blocker" provision. F3 · balance_after: The number of shares owned by Alpha does not include any shares issued to Lane Ventures, Inc., a consultant of the Issuer. Alpha disclaims beneficial ownership of any of the shares issued to Lane Ventures, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.